Radiation oncology always seeks to strike the right balance between cancer control and the risk of treatment toxicity. As our understanding and...
Category - Uncategorized
Usually, we discuss newly published cancer research for the journal club. Next weekend, we will discuss a new way for training physicians to organize...
For our September #radonc journal club we will discuss twice-daily versus daily chemoradiation for limited stage small cell lung cancer (LS-SCLC)...
What are the key elements of leadership in radiation oncology? How do we teach it so that radiation oncologists can maintain a leading role in cancer...
Surgery is the current gold standard for operable clinical stage I non-small cell lung cancer, but stereotactic ablative radiotherapy (SABR) works...
For the November journal club we will discuss a phase II trial of chemoradiation de-escalation for oropharyngeal cancer. Human papillomavirus (HPV)...
Last month we discussed RTOG 0617, in which one of the randomization added cetuximab to standard chemotherapy for concurrent chemoradiation. The...
The March 2015 #RadOnc journal club will be discussing the article: Factors influencing the use of RT in NSW: a qualitative study exploring...
Thank you to all the participants in our first four chats. It’s been a great beginning to the radiation oncology journal club – we have...